Interferon and ribavirin therapy in dialysis patients with chronic hepatitis C

被引:19
作者
Bruchfeld, A [1 ]
Ståhle, L
Andersson, J
Schvarcz, R
机构
[1] Karolinska Inst, Div Renal Med, Stockholm, Sweden
[2] Karolinska Inst, Div Clin Pharmacol, Stockholm, Sweden
[3] Karolinska Inst, Div Infect Dis, Stockholm, Sweden
[4] Huddinge Univ Hosp, Stockholm, Sweden
关键词
D O I
10.1093/ndt/16.8.1729
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
引用
收藏
页码:1729 / 1729
页数:1
相关论文
共 3 条
[1]  
BRUCHFELD A, IN PRESS J VIRAL HEP
[2]   Determination of ribavirin in serum using highly selective solid-phase extraction and high-performance liquid chromatography [J].
Svensson, JO ;
Bruchfeld, A ;
Schvarcz, R ;
Ståhle, L .
THERAPEUTIC DRUG MONITORING, 2000, 22 (02) :215-218
[3]   Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study [J].
Tan, ACITL ;
Brouwer, JT ;
Glue, P ;
van Leusen, R ;
Kauffmann, RH ;
Schalm, SW ;
de Vries, RA ;
Vroom, B .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (01) :193-195